Abiopharma

🔍 HAFT IAN DAVID (Director)

Company: OCTAVE SPECIALTY GROUP INC (OSG)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 7,441 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 16,091.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Octave Specialty Group, Inc. (the "Company").
• F2: RSU's granted on April 1, 2026 shall vest one year later on April 1, 2027. RSUs that have become vested shall settle and convert into shares of common stock upon the earlier of the vesting date or the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company, unless otherwise deferred upon the election of the Reporting person.